# Göteborg University

Organization · id `cardio:org-goteborg-university` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=G%C3%B6teborg+University>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 9 trials in this atlas.

## Technical summary

Sponsor class other. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: Göteborg University
- Sponsor class: OTHER

## Connected pages

- Sponsors: GOThenburg Very Early Supported Discharged (`cardio:ct-nct01622205`)
- Sponsors: Optimized Management of Comorbidity in Heart Failure With Preserved Ejection Fraction in the Elderly (&gt;60 Years) (`cardio:ct-nct02425371`)
- Sponsors: Pharmaceutical Treatment of Fatigue After Aneurysmal Subarachnoid Hemorrhage (`cardio:ct-nct03209830`)
- Sponsors: Ticagrelor and ASA vs. ASA Only After Isolated Coronary Artery Bypass Grafting in Patients With Acute Coronary Syndrome (`cardio:ct-nct03560310`)
- Sponsors: Randomized Evaluation of Beta Blocker and ACEI/ARB Treatment in MINOCA Patients - MINOCA-BAT (`cardio:ct-nct03686696`)
- Sponsors: Effects of Measurement of Handgrip Strength on Physical Activity Level for Patients With Diabetes Type 2 (`cardio:ct-nct03693521`)
- Sponsors: BROKEN-SWEDEHEART- Optimized Pharmacological Treatment for Broken Heart (Takotsubo) Syndrome. (`cardio:ct-nct04666454`)
- Sponsors: OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosilicate in Heart Failure (`cardio:ct-nct04789239`)
- Sponsors: SGLT2 Inhibitor TrEatment iN Patients Awaiting cOronary arTery bYpass Surgery to Reduce Post-opErative AF (`cardio:ct-nct05852704`)

## Provenance

Content hash: 445fbc04c0684192c4193d103ff1de27703216ab8fd3b2d4a7f1e1881fadb3e9
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
